Ueda K
Department of Applied Life Science, Kyoto University Graduate School.
Nihon Rinsho. 1997 May;55(5):1024-9.
ATP-binding cassette(ABC) superfamily transporters, including P-glycoprotein and MRP, actively transport various structurally dissimilar chemotherapeutic compounds out of cancer cells and confer multidrug resistance. Members of ABC superfamily which may extrude anti-cancer drugs are still expanding, thus the importance of these proteins are further increasing for cancer chemotherapy. Multidrug resistance will be acquired either by the induction of expression of ABC superfamily transporters or by mutations of ABC superfamily genes which cause amino acids substitutions. We recently found that amino acid substitutions in the first predicted transmembrane domain of P-glycoprotein increase the ability to confer resistance to important anti-cancer drugs adriamycin and VP-16. The mechanisms for drug recognition and transport of human P-glycoprotein and MRP are discussed.
ATP结合盒(ABC)超家族转运蛋白,包括P-糖蛋白和多药耐药相关蛋白(MRP),可将各种结构不同的化疗化合物主动转运出癌细胞,从而赋予多药耐药性。可能排出抗癌药物的ABC超家族成员仍在不断增加,因此这些蛋白质在癌症化疗中的重要性也在进一步提高。多药耐药性可通过诱导ABC超家族转运蛋白的表达或通过导致氨基酸替代的ABC超家族基因突变而获得。我们最近发现,P-糖蛋白第一个预测跨膜结构域中的氨基酸替代增加了对重要抗癌药物阿霉素和依托泊苷的耐药能力。本文讨论了人类P-糖蛋白和MRP的药物识别及转运机制。